These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The assessment and management of albuminuria in primary care. Thomas MC Diabetes Res Clin Pract; 2008 Apr; 80(1):83-8. PubMed ID: 18093680 [TBL] [Abstract][Full Text] [Related]
23. [Prediction, screening and treatment of renal complications of diabetes]. Marre M; Larger E Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120 [TBL] [Abstract][Full Text] [Related]
24. [Nephropathy in type 2 diabetes mellitus]. Fliser D; Haller H Internist (Berl); 2000 Dec; 41(12):1363-73. PubMed ID: 11189071 [No Abstract] [Full Text] [Related]
25. [Diagnostic parameter in early diabetic nephropathy]. Yamazaki C; Shibata M Nihon Rinsho; 1991 Feb; 49 Suppl():125-30. PubMed ID: 2033798 [No Abstract] [Full Text] [Related]
26. [Diabetic nephropathy. A historical, clinical and diagnostic framework]. Conti AA Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167 [TBL] [Abstract][Full Text] [Related]
27. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes? Danne T; Kordonouri O J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():347-63. PubMed ID: 9642665 [TBL] [Abstract][Full Text] [Related]
28. [Diabetic nephropathy. IIa]. Serban V; Băcanu GS; Serban M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):295-306. PubMed ID: 2573940 [No Abstract] [Full Text] [Related]
29. Kidney disease in diabetology: lessons from 2008. Schernthaner G Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896 [No Abstract] [Full Text] [Related]
30. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]
31. [Antihypertensive treatment in type II diabetes and diabetic nephropathy]. Chantrel F; Bouiller M; Kolb I; Hannedouche T Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204 [TBL] [Abstract][Full Text] [Related]
32. [Examination of the kidneys in a diabetic patient]. Tesar V Vnitr Lek; 2008 May; 54(5):494-8. PubMed ID: 18630635 [TBL] [Abstract][Full Text] [Related]
33. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Koshimura J; Fujita H; Narita T; Shimotomai T; Hosoba M; Yoshioka N; Kakei M; Fujishima H; Ito S Biochem Biophys Res Commun; 2004 Mar; 316(1):165-9. PubMed ID: 15003525 [TBL] [Abstract][Full Text] [Related]
34. [Nephropathy: an overview for daily practice]. Pittrow D; Wittchen HU; Bramlage P; Dikow R; Kirch W; Lehnert H; Ritz E Fortschr Med Orig; 2003 Feb; 121 Suppl 1():39-44. PubMed ID: 14732949 [TBL] [Abstract][Full Text] [Related]
35. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes]. Qin LX; Zeng X; Huang G Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917 [TBL] [Abstract][Full Text] [Related]
36. Diabetic nephropathy: has the time come to move beyond plasma creatinine? Osman MM; Ahmed MH Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625 [No Abstract] [Full Text] [Related]
37. [Early detection and control of risk factors in diabetic nephropathy]. Fernández López MT; Isidro San Juan ML; Cordido F An Med Interna; 1998 Nov; 15(11):600-5. PubMed ID: 9882860 [TBL] [Abstract][Full Text] [Related]
38. [Diabetic nephropathy - current concepts in early diagnosis and treatment of diabetic microvascular complications]. Meier M; Haller H Herz; 2004 Aug; 29(5):496-503. PubMed ID: 15340735 [TBL] [Abstract][Full Text] [Related]